Pacific Biosciences of California, Inc. (PACB)
2.35
-0.01
(-0.42%)
USD |
NASDAQ |
Jan 15, 16:00
2.31
-0.04
(-1.70%)
After-Hours: 20:00
Pacific Biosciences of California SG&A Expense (TTM): 149.08M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 119.17M |
| Twist Bioscience Corp. | 246.98M |
| Beam Therapeutics, Inc. | 110.20M |
| Boston Scientific Corp. | 6.666B |
| Bruker Corp. | 946.60M |